Hello GFPs, and let’s start with the good news this week: the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has, for the first time ever, done a thorough analysis of the clinical trials conducted in this country.
Hooray!
Now, if you click on that link, you may be confused about why I’m framing this as good news, and admittedly, the MHRA…